Chase Science's reinvestment for growth seems ineffective as...

Chase Science's reinvestment for growth seems ineffective as sales remain stagnant, leading to concerns over diminishing returns. The decrease in ROCE may be due to the company funding more operations with its own money, potentially reducing efficiency.